Back to results
US 7,407,764 B2Granted
Plasma C5A levels as an indicator of asthma severity
AssigneeThe Research Foundation of State University of New York
InventorsRauno Joks, Hazel P. Drew, Myrelle B. Castro, Nandita Mathur Khaneja
Life of this patent
Estimating the term…
Abstract
This invention provides the first blood test which characterizes asthma severity. More specifically, the present invention provides methods of determining the severity of acute asthma in a patient by determining the levels of C5a or C5a-desArg in the patient's blood, plasma or serum.
Claims5
A method of determining the severity of asthma in an adult asthma patient comprising:
- (a) obtaining a blood sample from an adult patient having asthma;
- (b) determining the level of C5a-desArg in the blood of said patient, wherein an elevated level of the C5a-desArg correlates with an increased severity of asthma in said patient.
Dependencies are inferred from the claim text.